SCHEMBL30210973

SCHEMBL30210973

CC1(NC(=O)c2cc(C(=O)c3sc(Nc4ccc(F)c(F)c4)nc3N)on2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 8/20 0.46
MAPT P10636 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
POLB P06746 1/20 0.43
CCNT1 O60563 1/20 0.41
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
CDK9 P50750 1/20 0.41
CDK6 Q00534 1/20 0.41
CDK11A Q9UQ88 1/20 0.41
CDK5 Q00535 4/20 0.41
CDK5R1 Q15078 4/20 0.41
TP53 P04637 2/20 0.41
LMNA P02545 1/20 0.41
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23930533 1.00 CHRNA7 (0.46) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL23930549 0.90 MAPT (0.53) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL30210963 0.83 MAPT (0.45) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL23930591 0.83 MAPT (0.45) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL23930611 0.83 CCNA2 (0.50) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL31633457 0.83 CCNA2 (0.50) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL30210806 0.81 CHRNA7 (0.44) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL23930636 0.81 CHRNA7 (0.44) CHRNA7MAPTMEN1KMT2APOLB
SCHEMBL23930497 0.81 MEN1 (0.31) MAPTMEN1KMT2ACDK5CDK5R1
SCHEMBL25207573 0.81 MEN1 (0.31) MAPTMEN1KMT2ACDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115697979-B Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2025-06-24 CN disclosed
EP-4139287-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION Bayer Aktiengesellschaft (DE) 2023-03-01 EP disclosed